Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

XENEXENE
26 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in XENON PHARMACEUTICALS INC

Yes. Driehaus Capital Management holds 4,418,557 shares of XENE (Xenon Pharmaceuticals), worth $266.7M, as of its Q2 2026 13F filing. It reduced the position by 73,096 shares (-1.6%) from Q1 2026. Driehaus Capital Management has held XENE since Q1 2020, across 26 quarterly 13F filings. XENE is 1.5% of Driehaus Capital Management's reported 13F portfolio.

Current Value

$266.7M

Current Shares

4.4M

Total Value Change

+$261.5M

Total Shares Change

+4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.4M
-1.6%
$266.7M1.5%$60.36
0
2026-Q1
Decreased
4.5M
-1.0%
$261.2M1.9%$43.79
0
2025-Q4
Increased
4.5M
+8.9%
$203.4M1.4%$44.12
53
2025-Q3
Decreased
4.2M
-3.8%
$167.4M1.2%$39.06
0
2025-Q2
Decreased
4.3M
-5.4%
$135.7M1.1%$32.40
0
2025-Q1
Increased
4.6M
+1.4%
$153.8M1.5%$34.26
48
2024-Q4
Decreased
4.5M
-1.6%
$177.2M1.5%$38.53
0
2024-Q3
Increased
4.6M
+4.0%
$180.9M1.6%$38.65
50
2024-Q2
Increased
4.4M
+2.3%
$172.3M1.7%$38.99
49
2024-Q1
Decreased
4.3M
-0.5%
$186.1M1.9%$43.05
0
2023-Q4
Decreased
4.3M
-3.7%
$200.1M2.4%$46.06
0
2023-Q3
Decreased
4.5M
-5.2%
$154.2M2.0%$34.16
0
2023-Q2
Increased
4.8M
+2.3%
$183.3M2.3%$38.43
53
2023-Q1
Decreased
4.7M
-0.6%
$166.6M2.3%$35.61
0
2022-Q4
Increased
4.7M
+4.0%
$184.6M2.8%$39.43
54
2022-Q3
Increased
4.5M
+2.6%
$162.6M2.5%$35.89
53
2022-Q2
Increased
4.4M
+33.0%
$133.6M2.2%$30.90
66
2022-Q1
Increased
3.3M
+5.7%
$100.9M1.2%$30.12
50
2021-Q4
Increased
3.1M
+106.6%
$97.6M1.0%$31.99
68
2021-Q3
Increased
1.5M
+59.9%
$23.1M0.3%$14.86
49
2021-Q2
Increased
945,135
+22.5%
$17.6M0.2%$18.05
41
2021-Q1
Increased
771,410
+73.2%
$13.8M0.2%$17.49
50
2020-Q4
Decreased
445,444
-1.3%
$6.9M0.1%$16.04
0
2020-Q3
Decreased
451,307
-2.8%
$5M0.1%$10.83
0
2020-Q2
Increased
464,233
+0.4%
$5.8M0.1%$12.01
32
2020-Q1
New
462,332
-
$5.2M0.2%$10.96
45

Other major holders of XENE: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used